Logo image of HAO

HAOXI HEALTH TECHNOLOGY LTD (HAO) Stock Fundamental Analysis

NASDAQ:HAO - Nasdaq - KYG4290F1000 - Common Stock - Currency: USD

1.85  -0.01 (-0.54%)

After market: 1.94 +0.09 (+4.86%)

Fundamental Rating

5

Overall HAO gets a fundamental rating of 5 out of 10. We evaluated HAO against 93 industry peers in the Media industry. HAO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. HAO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

HAO had positive earnings in the past year.
HAO had a negative operating cash flow in the past year.
HAO Yearly Net Income VS EBIT VS OCF VS FCFHAO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M 2M

1.2 Ratios

Looking at the Return On Assets, with a value of 13.23%, HAO belongs to the top of the industry, outperforming 94.25% of the companies in the same industry.
HAO's Return On Equity of 18.20% is amongst the best of the industry. HAO outperforms 86.21% of its industry peers.
Looking at the Return On Invested Capital, with a value of 15.84%, HAO belongs to the top of the industry, outperforming 96.55% of the companies in the same industry.
Industry RankSector Rank
ROA 13.23%
ROE 18.2%
ROIC 15.84%
ROA(3y)25.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HAO Yearly ROA, ROE, ROICHAO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

HAO has a Profit Margin of 2.85%. This is in the better half of the industry: HAO outperforms 60.92% of its industry peers.
HAO's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 3.52%, HAO is doing worse than 60.92% of the companies in the same industry.
In the last couple of years the Operating Margin of HAO has grown nicely.
Looking at the Gross Margin, with a value of 5.49%, HAO is doing worse than 89.66% of the companies in the same industry.
In the last couple of years the Gross Margin of HAO has grown nicely.
Industry RankSector Rank
OM 3.52%
PM (TTM) 2.85%
GM 5.49%
OM growth 3Y11.17%
OM growth 5YN/A
PM growth 3Y4.01%
PM growth 5YN/A
GM growth 3Y6.32%
GM growth 5YN/A
HAO Yearly Profit, Operating, Gross MarginsHAO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2 4 6

More info and screens

7

2. Health

2.1 Basic Checks

HAO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for HAO has been reduced compared to 1 year ago.
Compared to 1 year ago, HAO has an improved debt to assets ratio.
HAO Yearly Shares OutstandingHAO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
HAO Yearly Total Debt VS Total AssetsHAO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

HAO has an Altman-Z score of 6.88. This indicates that HAO is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.88, HAO belongs to the top of the industry, outperforming 93.10% of the companies in the same industry.
HAO has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of HAO (0.10) is better than 75.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 6.88
ROIC/WACC2.31
WACC6.85%
HAO Yearly LT Debt VS Equity VS FCFHAO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

A Current Ratio of 3.98 indicates that HAO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.98, HAO belongs to the top of the industry, outperforming 94.25% of the companies in the same industry.
A Quick Ratio of 3.98 indicates that HAO has no problem at all paying its short term obligations.
HAO's Quick ratio of 3.98 is amongst the best of the industry. HAO outperforms 94.25% of its industry peers.
Industry RankSector Rank
Current Ratio 3.98
Quick Ratio 3.98
HAO Yearly Current Assets VS Current LiabilitesHAO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

HAO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.02%, which is quite impressive.
The Earnings Per Share has been growing by 61.61% on average over the past years. This is a very strong growth
Looking at the last year, HAO shows a very strong growth in Revenue. The Revenue has grown by 92.62%.
The Revenue has been growing by 55.73% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)53.02%
EPS 3Y61.61%
EPS 5YN/A
EPS Q2Q%38.76%
Revenue 1Y (TTM)92.62%
Revenue growth 3Y55.73%
Revenue growth 5YN/A
Sales Q2Q%71.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HAO Yearly Revenue VS EstimatesHAO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M
HAO Yearly EPS VS EstimatesHAO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.43, which means the current valuation is very expensive for HAO.
The rest of the industry has a similar Price/Earnings ratio as HAO.
Compared to an average S&P500 Price/Earnings ratio of 29.63, HAO is valued at the same level.
Industry RankSector Rank
PE 26.43
Fwd PE N/A
HAO Price Earnings VS Forward Price EarningsHAO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.64
HAO Per share dataHAO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HAO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HAOXI HEALTH TECHNOLOGY LTD

NASDAQ:HAO (2/21/2025, 8:25:06 PM)

After market: 1.94 +0.09 (+4.86%)

1.85

-0.01 (-0.54%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.99%
Inst Owner Change56.93%
Ins Owners21.79%
Ins Owner ChangeN/A
Market Cap5.22M
Analysts0
Price TargetN/A
Short Float %N/A
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 26.43
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB 0.46
EV/EBITDA -0.64
EPS(TTM)0.07
EY3.78%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS25.54
BVpS4
TBVpS4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.23%
ROE 18.2%
ROCE 21.78%
ROIC 15.84%
ROICexc 35.58%
ROICexgc 35.58%
OM 3.52%
PM (TTM) 2.85%
GM 5.49%
FCFM N/A
ROA(3y)25.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.92%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y11.17%
OM growth 5YN/A
PM growth 3Y4.01%
PM growth 5YN/A
GM growth 3Y6.32%
GM growth 5YN/A
F-Score3
Asset Turnover4.64
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 0.45
Cap/Depr 523.84%
Cap/Sales 0.08%
Interest Coverage 68.03
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.98
Quick Ratio 3.98
Altman-Z 6.88
F-Score3
WACC6.85%
ROIC/WACC2.31
Cap/Depr(3y)486.99%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.11%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.02%
EPS 3Y61.61%
EPS 5YN/A
EPS Q2Q%38.76%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)92.62%
Revenue growth 3Y55.73%
Revenue growth 5YN/A
Sales Q2Q%71.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y50.16%
EBIT growth 3Y73.12%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.28%
OCF growth 3YN/A
OCF growth 5YN/A